• British Pharmacopoeia Volume V
  • Appendices
  • Appendix XV Production and Testing of Vaccines

Appendix XV A. Terminology used in Monographs on Biological Products

(Ph. Eur. method 5.2.1)

For some items, alternative terms commonly used in connection with veterinary vaccines are shown in parenthesis.

Seed-lot system A seed-lot system is a system according to which successive batches of a product are derived from the same master seed lot. For routine production, a working seed lot may be prepared from the master seed lot. The origin and the passage history of the master seed lot and the working seed lot are recorded.

Master seed lot A culture of a micro-organism distributed from a single bulk into containers and processed together in a single operation in such a manner as to ensure uniformity and stability and to prevent contamination. A master seed lot in liquid form is usually stored at or below - 70 °C. A freeze-dried master seed lot is stored at a temperature known to ensure stability.

Working seed lot A culture of a micro-organism derived from the master seed lot and intended for use in production. Working seed lots are distributed into containers and stored as described above for master seed lots.

Cell-bank system (Cell-seed system) A system whereby successive final lots (batches) of a product are manufactured by culture in cells derived from the same master cell bank (master cell seed). A number of containers from the master cell bank (master cell seed) are used to prepare a working cell bank (working cell seed). The cell-bank system (cell-seed system) is validated for the highest passage level achieved during routine production.

Master cell bank (Master cell seed) A culture of cells distributed into containers in a single operation, processed together and stored in such a manner as to ensure uniformity and stability and to prevent contamination. A master cell bank (master cell seed) is usually stored at - 70 °C or lower.

Working cell bank (Working cell seed) A culture of cells derived from the master cell bank (master cell seed) and intended for use in the preparation of production cell cultures. The working cell bank (working cell seed) is distributed into containers, processed and stored as described for the master cell bank (master cell seed).

Primary cell cultures Cultures of cells obtained by trypsination of a suitable tissue or organ. The cells are essentially identical to those of the tissue of origin and are no more than 5 in vitro passages from the initial preparation from the animal tissue.

Cell lines Cultures of cells that have a high capacity for multiplication in vitro. In diploid cell lines, the cells have essentially the same characteristics as those of the tissue of origin. In continuous cell lines, the cells are able to multiply indefinitely in culture and may be obtained from healthy or tumoral tissue. Some continuous cell lines have oncogenic potential under certain conditions.

Production cell culture A culture of cells intended for use in production; it may be derived from one or more containers of the working cell bank (working cell seed) or it may be a primary cell culture.

Control cells A quantity of cells set aside, at the time of virus inoculation, as uninfected cell cultures. The uninfected cells are incubated under similar conditions to those used for the production cell cultures.

Single harvest Material derived on one or more occasions from a single production cell culture inoculated with the same working seed lot or a suspension derived from the working seed lot, incubated, and harvested in a single production run.

Monovalent pooled harvest Pooled material containing a single strain or type of micro-organism or antigen and derived from a number of eggs, cell culture containers etc. that are processed at the same time.

Final bulk vaccine Material that has undergone all the steps of production except for the final filling. It consists of one or more monovalent pooled harvests, from cultures of one or more species or types of micro-organism, after clarification, dilution or addition of any adjuvant or other auxiliary substance. It is treated to ensure its homogeneity and is used for filling the containers of one or more final lots (batches).

Final lot (Batch) A collection of closed, final containers or other final dosage units that are expected to be homogeneous and equivalent with respect to risk of contamination during filling or preparation of the final product. The dosage units are filled, or otherwise prepared, from the same final bulk vaccine, freeze-dried together (if applicable) and closed in one continuous working session. They bear a distinctive number or code identifying the final lot (batch). Where a final bulk vaccine is filled and/or freeze-dried on several separate sessions, there results a related set of final lots (batches) that are usually identified by the use of a common part in the distinctive number or code; these related final lots (batches) are sometimes referred to as sub-batches, sub-lots or filling lots.

Combined vaccine A multicomponent preparation formulated so that different antigens are administered simultaneously. The different antigenic components are intended to protect against different strains or types of the same organism and/or different organisms. A combined vaccine may be supplied by the manufacturer either as a single liquid or freeze-dried preparation or as several constituents with directions for admixture before use.